Voluntary MFN commitments by 16 manufacturers reportedly cover ~70% of Medicare drug spending, potentially obviating GUARD/GLOBE finalization while avoiding predictable legal challenges. Lindsay ...
In recent months – as credit spreads have continued to widen – sponsors, borrowers and lenders alike have frequently found themselves combing through their loan documents to check the scope of the ...
The White House is planning to officially launch its direct-to-consumer, lower-cost drug platform TrumpRx Thursday evening, unveiling the results of President Trump’s “most favored nation” (MFN) drug ...
On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...
This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks. US ...
In a new survey of health policy experts conducted by the Cornell Health Policy Center, respondents expressed uncertainty about the effects of a most favored nation (MFN) prescription drug pricing ...
The Trump administration reignited the U.S. drug pricing debate by signing a sweeping Executive Order on May 12, introducing a “Most Favored Nation” (MFN) pricing framework. This policy seeks to ...
It deprives congressional Democrats of the ability to take credit for Trump’s result or to look like reasonable, bipartisan people interested in collaborating with the president. And as Democratic ...
US MFN rules and new tariffs are narrowing the US–ex-US price gap and drawing more manufacturing and capital investment toward the United States. Low European or UK list prices now directly affect US ...
In recent months – as credit spreads have continued to widen – sponsors, borrowers and lenders alike have frequently found themselves combing through their loan documents to check the scope of the ...